How many patents does
Symphogen have?
patents
488
families
39
granted
89
applications
399
US
57
EP
53
WO
36
CN
33
KR
29
JP
14
RoW
266
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Symphogen
Top ten assignees appearing on patents
2009 - 2018
| symphogen | 411 |
| meiji seika pharma | 34 |
| receptor biologix | 8 |
| simfogen | 3 |
| andersen corporation | 1 |
| receptor biolog | 1 |
| synageva biopharma corporation | 1 |
2009
| symphogen | 47 |
| receptor biologix | 5 |
2018
| symphogen | 28 |
Symphogen
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| recombinant anti-epidermal growth factor receptor antibody compositions | 39 | 2007 |
| pan-her antibody composition | 37 | 2010 |
| a procedure for characterization of a polyclonal cell line | 33 | 2004 |
| antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa | 33 | 2010 |
| method for manufacturing a recombinant polyclonal protein | 30 | 2007 |
| recombinant anti-epidermal growth factor receptor antibody compositions | 26 | 2008 |
| method for cloning cognate antibodies | 25 | 2007 |
| method for linking sequences of interest | 24 | 2003 |
| humanized pan-her antibody compositions | 21 | 2012 |
| a method for characterization of a recombinant polyclonal protein | 15 | 2007 |